APPLICATION
ANDA083559
TYPE
ANDA
ORIGINAL APPROVAL
1973-12-04
LATEST ACTION
1994-08-10
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
MEPIVACAINE HYDROCHLORIDEDiscontinued
MEPIVACAINE HYDROCHLORIDE 3% · INJECTABLE · INJECTION
Approval history
1994-08-10Labeling · Supplement 23AP
1993-03-04Labeling · Supplement 22AP
1990-10-25Labeling · Supplement 21AP
1989-11-29Labeling · Supplement 20AP
1988-11-03Manufacturing (CMC) · Supplement 19AP
1987-11-04Manufacturing (CMC) · Supplement 17AP
1985-01-31Manufacturing (CMC) · Supplement 13AP
1985-01-31Manufacturing (CMC) · Supplement 14AP
1983-10-20Manufacturing (CMC) · Supplement 11AP
1973-12-04OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.